Evidence map›Paper›PMID 40830634›Full record

ArticleScientific reports2025

Conditional immortalization of olfactory ensheathing cells for intelligently regulating their proliferation state.

Chengyi Zhang, Wanzhu Hao, Yubing Yang, Jiaxi Li, Qiongchi Zhang, Su'e Chang, Kun Yang, Xijing He

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Chengyi ZhangDepartment of Orthopaedics, the Second Affiliated Hospital, School of Medicine, Xi'an Jiaotong University, Xi'an, China.
Wanzhu HaoDepartment of Orthopaedics, the Second Affiliated Hospital, School of Medicine, Xi'an Jiaotong University, Xi'an, China.
Yubing YangDepartment of Orthopaedics, the Second Affiliated Hospital, School of Medicine, Xi'an Jiaotong University, Xi'an, China.
Jiaxi LiDepartment of Orthopaedics, the Second Affiliated Hospital, School of Medicine, Xi'an Jiaotong University, Xi'an, China.
Qiongchi ZhangDepartment of Orthopaedics, the Second Affiliated Hospital, School of Medicine, Xi'an Jiaotong University, Xi'an, China.
Su'e ChangDepartment of Orthopaedics, the Second Affiliated Hospital, School of Medicine, Xi'an Jiaotong University, Xi'an, China.
Kun YangDepartment of Neurorehabilitation, Xi'an International Medical Center Hospital, Xi'an, China.
Xijing HeDepartment of Orthopaedics, the Second Affiliated Hospital, School of Medicine, Xi'an Jiaotong University, Xi'an, China. xijing_h@vip.tom.com.

Funding

the National Natural Science Foundation of China 82372417the Natural Science Foundation of Xi'an 23KGDW0015-2022
6 · The paper itself

Abstract

Olfactory ensheathing cells (OECs) are among the most promising cell types for the treatment of spinal cord injury (SCI) and other neural traumas. However, primary OECs cultured in vitro are constrained by their inherent "Hayflick limit," resulting in poor proliferative and passaging capacities, which restricts their large-scale application in both basic and clinical research. Conditional immortalization technology provides an excellent solution for rapid, large-scale, and controllable proliferation of primary OECs. However, few studies have applied this approach to the controlled passaging of OECs. Here, we used the tetracycline-controlled system (Tet-On system) to introduce the HBLV-TetOn-SV40Tag-PURO constructed into the primary OECs via lentiviral transfection, establishing a conditionally immortalized OEC line. We comprehensively investigated its functional characteristics with or without tetracycline conditions by using immunofluorescence, qPCR, CCK-8, Scratch assay, and Transwell migration experiment. Our results demonstrated that this cell line could rapidly proliferate under tetracycline and quickly recover to proliferation and migration levels similar to primary OECs after tetracycline removal following multiple passages. This approach ensures obtaining a suitable quantity of OECs with specific functional characteristics while avoiding the malignant proliferation risks associated with traditional cell line establishment, thus offering higher safety. Moreover, the method is simple to operate, cost-effective, possessing excellent potential for basic and clinical translational applications.

Indexed as

Cell ProliferationNeurogliaOlfactory BulbAnimalsCell MovementCells, CulturedLentivirusRatsSpinal Cord InjuriesTetracyclineTetracycline

Identifiers

PMID40830634
PMCPMC12365035

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.